griseofulvin and pregnancy
Last reviewed 01/2018
Griseofulvin induces aneuploidy and therefore is a potential teratogen. Therefore it has been advised that both men and women should use contraception whilst taking griseofulvin.
- men - should avoid fathering children during treatment and up to six months
after griseofulvin has been stopped
- women - should not become pregnant whilst taking griseofulvin or within one month of stopping treatment
Reference:
- Committee on Safety of Medicines (1996). Griseofulvin: contraceptive precautions. Current Problems in Pharmacovigilance, 22, 8.